Search details
1.
Hepatic steatosis, metabolic dysfunction and risk of mortality: findings from a multinational prospective cohort study.
BMC Med
; 22(1): 221, 2024 Jun 03.
Article
in English
| MEDLINE | ID: mdl-38825687
2.
Prospective surveillance for cholangiocarcinoma in unselected individuals with primary sclerosing cholangitis.
J Hepatol
; 78(3): 604-613, 2023 03.
Article
in English
| MEDLINE | ID: mdl-36410555
3.
Impact on follow-up strategies in patients with primary sclerosing cholangitis.
Liver Int
; 43(1): 127-138, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35535655
4.
Clinical outcomes and sick leave in relation to UDCA treatment in Swedish patients with primary biliary cholangitis.
Scand J Gastroenterol
; 58(1): 70-75, 2023 01.
Article
in English
| MEDLINE | ID: mdl-35993428
5.
What is the significance of the Hill classification?
Dis Esophagus
; 36(9)2023 Sep 01.
Article
in English
| MEDLINE | ID: mdl-36744860
6.
Prediagnostic alterations in circulating bile acid profiles in the development of hepatocellular carcinoma.
Int J Cancer
; 150(8): 1255-1268, 2022 04 15.
Article
in English
| MEDLINE | ID: mdl-34843121
7.
Morbidity, risk of cancer and mortality in 3645 HFE mutations carriers.
Liver Int
; 41(3): 545-553, 2021 03.
Article
in English
| MEDLINE | ID: mdl-33450138
8.
Self-monitoring with home based fecal calprotectin is associated with increased medical treatment. A randomized controlled trial on patients with inflammatory bowel disease.
Scand J Gastroenterol
; 56(1): 38-45, 2021 Jan.
Article
in English
| MEDLINE | ID: mdl-33284639
9.
Extrahepatic autoimmune diseases in primary biliary cholangitis: Prevalence and significance for clinical presentation and disease outcome.
J Gastroenterol Hepatol
; 36(4): 936-942, 2021 Apr.
Article
in English
| MEDLINE | ID: mdl-32790935
10.
Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study.
J Hepatol
; 70(5): 885-892, 2019 05.
Article
in English
| MEDLINE | ID: mdl-30582978
11.
Validation of Risk Scoring Systems in Ursodeoxycholic Acid-Treated Patients With Primary Biliary Cholangitis.
Am J Gastroenterol
; 114(7): 1101-1108, 2019 07.
Article
in English
| MEDLINE | ID: mdl-31241547
12.
Tacrolimus and Mycophenolate Mofetil as Second-Line Therapies for Pediatric Patients with Autoimmune Hepatitis.
Dig Dis Sci
; 63(5): 1348-1354, 2018 May.
Article
in English
| MEDLINE | ID: mdl-29569003
13.
Circulating copper and zinc levels and risk of hepatobiliary cancers in Europeans.
Br J Cancer
; 116(5): 688-696, 2017 Feb 28.
Article
in English
| MEDLINE | ID: mdl-28152549
14.
Efficacy and Safety of Mycophenolate Mofetil and Tacrolimus as Second-line Therapy for Patients With Autoimmune Hepatitis.
Clin Gastroenterol Hepatol
; 15(12): 1950-1956.e1, 2017 Dec.
Article
in English
| MEDLINE | ID: mdl-28603052
15.
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study.
BMC Med
; 15(1): 72, 2017 04 04.
Article
in English
| MEDLINE | ID: mdl-28372583
16.
Epidemiology and causes of death in a Swedish cohort of patients with autoimmune hepatitis.
Scand J Gastroenterol
; 52(9): 1022-1028, 2017 Sep.
Article
in English
| MEDLINE | ID: mdl-28562110
17.
Safety of azathioprine and 6-mercaptopurine in patients with inflammatory bowel disease naïve to thiopurine treatmentâ©.
Int J Clin Pharmacol Ther
; 55(7): 594-600, 2017 Jul.
Article
in English
| MEDLINE | ID: mdl-28406092
18.
Alteration of amino acid and biogenic amine metabolism in hepatobiliary cancers: Findings from a prospective cohort study.
Int J Cancer
; 138(2): 348-60, 2016 Jan 15.
Article
in English
| MEDLINE | ID: mdl-26238458
19.
Pregnancy and childbirth in women with autoimmune hepatitis is safe, even in compensated cirrhosis.
Scand J Gastroenterol
; 51(4): 479-85, 2016.
Article
in English
| MEDLINE | ID: mdl-26631429
20.
Prediagnostic circulating vitamin D levels and risk of hepatocellular carcinoma in European populations: a nested case-control study.
Hepatology
; 60(4): 1222-30, 2014 Oct.
Article
in English
| MEDLINE | ID: mdl-24644045